Medical Devices: Page
-
Edwards CEO Mussallem to retire, Bernard Zovighian named successor
Michael Mussallem will step down in May after leading the company for more than 20 years.
By Elise Reuter • Dec. 8, 2022 -
AdvaMed asks FDA to withdraw divisive draft guidance on LASIK surgery
Some comments were more supportive, with the American Optometric Association calling the agency’s proposal “timely and beneficial.”
By Nick Paul Taylor • Dec. 8, 2022 -
Explore the Trendline➔
Sarah Silbiger via Getty Images
TrendlineTop 5 stories from MedTech Dive
From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
FDA outlines benefits and risks of emerging augmented and virtual reality medical devices
AR/VR may increase access to healthcare and make procedures less invasive, but could potentially cause cybersickness and head and neck strain.
By Nick Paul Taylor • Dec. 8, 2022 -
Apple prevails in AliveCor patent dispute ahead of potential Watch import ban
Patent board ruled that all 30 claims are unpatentable because they are obvious in view of other patents.
By Nick Paul Taylor • Dec. 8, 2022 -
Stanford’s smart bandages accelerate wound healing in preclinical tests
The bandages deliver electrical stimulation to accelerate wound healing in mice by 25% compared to standard sterile dressings.
By Nick Paul Taylor • Dec. 7, 2022 -
Ekso Bionics buys Indego lower limb exoskeleton business from Parker Hannifin for $10M
Indego and planned robotic assisted orthotic and prosthetic devices will slot into a portfolio of wearable robotics designed to tackle mobility loss.
By Nick Paul Taylor • Dec. 7, 2022 -
Retrieved from Medtronic on September 19, 2022
Excess deaths to continue constraining recovery of TAVR market in 2023: Goldman
Hospital staffing shortages and excess deaths among seniors are expected to slow the recovery of structural heart procedures, Goldman Sachs analysts said.
By Nick Paul Taylor • Dec. 7, 2022 -
Abiomed’s Impella RP heart pump finds use limited after FDA review of critically ill patients
It's a setback for the company, which hoped the right ventricle pump would have a wider use. A post-approval study showed a low survival rate for the sickest patients.
By Elise Reuter • Updated Dec. 6, 2022 -
Zimmer, Boston Scientific set to lead positive medical device pricing trend in 2023: analysts
As inflation rose, medical device companies were able to secure higher prices in large contracts, which Goldman Sachs analysts wrote “should only be the beginning.”
By Nick Paul Taylor • Dec. 6, 2022 -
AI detects prediabetes in CGM data, opening up new use for device: study
By correctly identifying many patients with prediabetes or Type 2 diabetes, researchers say CGMs can be used to prevent the disease.
By Nick Paul Taylor • Dec. 6, 2022 -
Reducing medtech waste: new PVC recycling process unlocks opportunity
Researchers have identified a way to recycle the PVC that is widely used in medical technologies such as tubing and blood bags.
By Nick Paul Taylor • Dec. 6, 2022 -
Getinge heart support devices join FDA shortage list as raw-materials supply slows production
Maintenance cycles for pumps and batteries have been extended and Getinge asked hospitals to share underutilized devices.
By Nick Paul Taylor • Dec. 5, 2022 -
Vulnerability in BD’s infusion pump flagged to US cybersecurity agency
An attacker with physical access to the device could exploit the vulnerability to change the configuration settings or disable the pump.
By Nick Paul Taylor • Updated Dec. 6, 2022 -
Medtech procedure volume pressures ease on healthcare hiring: Goldman
The evidence offers support for the analysts’ expectation that U.S. procedures will “modestly” improve next year in both inpatient and outpatient settings.
By Nick Paul Taylor • Dec. 5, 2022 -
The 10 biggest medtech stories of 2022
MedTech Dive reporting this year has explored how companies maintained momentum even amid supply shortages and rising inflation rates.
By MedTech Dive staff • Dec. 3, 2022 -
Integra to buy Surgical Innovation Associates for $50M in bid to lead growing breast reconstruction niche
Human-derived surgical matrices dominate the market but Interga thinks synthetic and xenograft devices will gain ground.
By Nick Paul Taylor • Dec. 2, 2022 -
Courtesy of https://news.medtronic.com/Left-Ventricular-Assist-Device-For-Advanced-Heart-Failure#assets_34137_10-122:19299
Medtronic’s HVAD system recalled again amid driveline cover problems
New issues have continued to surface with the problem-plagued device even after Medtronic pulled it from the market last year.
By Elise Reuter • Dec. 1, 2022 -
GE’s board finalizes healthcare spinoff
The new company, GE Healthcare, will be the sixth largest global medtech company when it starts trading on Nasdaq on Jan. 4.
By Elise Reuter • Dec. 1, 2022 -
Eargo raises $32M to fight rivals in over-the-counter hearing aid market
Investment firm takes majority stake, as Eargo faces competition from new rivals including Sony and Bose-partnered Lexie.
By Nick Paul Taylor • Dec. 1, 2022 -
European biomedical group backs delaying MDR certification deadline amid ‘looming crisis’
Pushing back the recertification deadline may buy time to address problems such as the shortage of capacity at certifying organizations.
By Nick Paul Taylor • Dec. 1, 2022 -
UroMems starts clinical trial of smart, automated implant to treat incontinence
The device is designed to improve on products such as Boston Scientific’s AMS 800 by eliminating the need for manual adjustments.
By Nick Paul Taylor • Nov. 30, 2022 -
Q&A
MedTech Innovators: Tissium co-founder Maria Pereira on taking tech from bench to bedside
The MIT-trained scientist explains how she went from PhD candidate to startup founder whose company is preparing to commercialize a range of products for use in reconstructing damaged tissue.
By Susan Kelly • Nov. 30, 2022 -
GE Healthcare, MediView XR partner to launch augmented reality X-ray imaging system
The companies are pitching the product as a response to physician demand for streamlined workflows and improved ergonomics.
By Nick Paul Taylor • Nov. 30, 2022 -
Medtronic touts benefits of latest Evolut TAVR system in retrospective analysis
Changes to the device improve alignment that is associated with improved coronary blood flow and valve hemodynamic performance.
By Nick Paul Taylor • Nov. 30, 2022 -
Boston Scientific to buy Apollo Endosurgery for $615M as entry into endobariatric market
The acquisition values Apollo shares at two-thirds above their closing price Monday, and may herald a new trend in medtech M&A, says an analyst.
By Elise Reuter • Nov. 29, 2022